Profile cover photo
Profile photo
Oncotheis
Oncotheis
Oncotheis
About
Posts

Post is pinned.Post has attachment
Public
On Spetembre 9-12, 2018
OncoTheis is participating to the 3rd edition of the European Association of Cancer research in Berlin. Join us at our booth to discuss in vitro lung solutions for your cancer research!
http://www.eacr.org/conference/goodbyeflatbiology2018/index
Photo
Add a comment...

Post has attachment
On Octobre 18, 2018
Christophe Mas, OncoTheis CSO, to speak at the European Parliament office in Paris as part of a discussion on the transition to scientific research without animals led by MEPs Pascal Durand and Younous Omarjee.
Accueil
Accueil
europarl.europa.eu
Add a comment...

Post has attachment
On June 4-7, 2018
OncoTheis will present its latest developments in the field of human lung cancer in vitro models at the BIO-Convention 2018 in Boston, USA. Meet us at our booth!

Photo
Add a comment...

Post has attachment
On July 1-4, 2018
OncoTheis is participating to the 18th European Congress on Biotechnology in Geneva, Switzerland.
Vsit our booth to discover how we are using gene editing to bio-engineer in vitro human lung models for efficacy and toxicity studies in the field of respiratory diseases and cancer.
http://www.ecb2018.com/
Photo
Add a comment...

Post has attachment
On June 12, 2018
Samuel Constant, OncoTheis CEO, will participate to the SME networking event « PME, comment bénéficier des réseaux de recherche du Grand Genève ? » organised in Archamps Technopole (France).
Add a comment...

Post has attachment
On April 26, 2018
OncoTheis cited among the key players of a fast expanding in vitro lung cancer model market
In Vitro Lung Model Market is a miniaturized and simplified version of an organ produced in vitro in 3D that shows realistic micro-anatomy. They are derived from human primary cells which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities. The technique for growing In Vitro Lung Model Market has rapidly improved since the early 2010s, and it was named by The Scientist as one of the biggest scientific advancements of 2013. In 2015, OncoTheis brought to the market a lung cancer in vitro model, OncoCilAir, allowing the pre-clinical testing of therapeutics in relevant physiological conditions.
Add a comment...

Post has attachment
On July 5-6, 2018
OncoTheis is participating to the unique LUNG IN VITRO event organised by Epithelix and AlterTox, by driving a full session dedicated to lung cancer. Join us next July in Nice, France !
http://www.epithelix.com/support/LIVe2018
Photo
Add a comment...

Post has attachment
On November 16-17, 2017
OncoTheis is participating to the CAAT Academy Workshop dedicated to In Vitro Lung Models in Geneva, Switzerland.
Among many topics, OncoTheis will present its in vitro 3D tissue model and assays to detect lung carcinogenesis.
http://academy.altertox.be/wp-content/uploads/2016/12/Epithelix-Agenda.pdf
Photo
Add a comment...

Post has attachment
On April 27, 2017
OncoTheis won the Run4Science 2017 Special Jury Award to develop in vitro models for immuno-oncology !

The Run4Science association aims to reduce animal experimentation by promoting alternative research methods and encouraging their use by the scientific community. Funds for projects are raised thanks to an annual fun run and through sponsorship. Next run: June 11, 2017 !
https://www.run4science.ch/
Photo
Add a comment...

Post has attachment
On November 24, 2017
Successful collaboration between OncoTheis and the GAP-Biophotonics laboratory of UNIGE revealed that the human lung cancer model OncoCilAir™ replicates in vitro the ability of tumors to influence surrounding healthy tissues.Read more in Scientific Reports:
https://www.nature.com/articles/s41598-017-16628-3.pdf
Photo
Add a comment...
Wait while more posts are being loaded